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Background The knowledge of the size of the gap
between esophageal ends in esophageal atresia (EA)
before surgery is of clinical importance. The aim of this
study was to compare the demographic characteristics
between patients with short-gap esophageal atresia
(SGEA) and long-gap esophageal atresia (LGEA).
Patients and methods Medical records of all patients
managed for EA spectrum in our department between 2003
and 2012 were evaluated, retrospectively. Demographic
data included the maternal age, the number of parities and
deliveries, the presence of polyhydramnios and the
prenatal diagnosis, sex, the gestational age and
prematurity, the type of delivery and the birth weight, age at
the time of diagnosis and treatment, the presence of
associated anomalies including VACTERL-type and non-
VACTERL-type anomalies, the type of EA according to
Gross classification, and discrepancies between the
diameters of atretic esophageal ends. SGEA and LGEA
were defined as a gap of less than three vertebral bodies
or three or more vertebral bodies in length between the
atretic esophageal ends, respectively.
Results There were 99 patients treated for the diagnosis
of EA spectrum during the study period: 81 in the SGEA
group and 18 in the LGEA group. Most of the parameters
studied did not differ between the two groups. Type-C EA
was more prevalent in patients with SGEA (n = 77/81) and
type-A was more frequent in children with LGEA (n = 8/18)
(P < 0.05). The frequency of prenatal diagnosis (2.5% for
SGEA vs. 22.2% for LGEA) was more common in the LGEA
group (P < 0.05). Cesarean section compared with normal
vaginal delivery was more commonly seen in both groups
(56.8% for SGEA vs. 66.7% for LGEA).
Conclusion Most of the demographic parameters were
similar between the two groups of patients. However, the
frequency of prenatal diagnosis was more common in
patients with LGEA. Most of the patients in both groups
were delivered by a cesarean section. Type-C EA was more
prevalent in patients with SGEA and type-A was more
frequent in children with LGEA. Further analysis of this
topic is warranted and may be beneficial in revealing the
true demographic differences between patients with SGEA
and LGEA. Ann Pediatr Surg 10:107–111 c 2014 Annals of
Pediatric Surgery.
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Hospital, İzmir, Turkey
Correspondence to Volkan Erikci, MD, Süvari Cad. Babadan Apt. No. 34 D.6,
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Introduction
Described as an interruption of the continuity of the
esophagus, esophageal atresia (EA) encompasses a group
of congenital anomalies and occurs in association with
tracheoesophageal fistula (TEF) or as an isolated
entity [1]. The knowledge of the size of the gap between
the atretic esophageal ends before surgery is of clinical
importance and it is also a prognostic indicator of
mortality and morbidity [2,3]. This clinical entity is
divided into short-gap esophageal atresia (SGEA) and
long-gap esophageal atresia (LGEA) depending on the
distance between the atretic esophageal segments.
The distance between the esophageal ends, which
constitutes SGEA and LGEA, lacks a strict numerical
definition and there are no uniformly accepted criteria
that define these entities. It has been reported that
LGEA has gap intervals measuring greater than 2 cm, with
a cutoff value of 2 cm or 2–3 vertebral bodies (VB) [4–6].
There are other suggested classifications in the literature
including the nomenclature of short, intermediate, and
long gap intervals with 1, 2.5, and 3 cm as the cutoff
points, respectively [3,7]. A 3.5-cm ‘ultralong’ gap has
also been described [8]. Epidemiological studies con-
cerning SGEA and LGEA are limited. Thus, we
conducted the present study to analyze the character-
istics of patients with SGEA and LGEA and to provide
valuable data on this issue. It was also aimed in the
current study to compare the demographic characteristics
between patients with SGEA and LGEA in the light of
relevant literature.
Patients and methods
Institutional ethical approval for the study was obtained.
Medical records of all patients managed for EA spectrum
in our department between 2003 and 2012 were
evaluated retrospectively. In defining the type of atresia,
SGEA and LGEA were described as a gap of less than
three VB or three or more VB in length between the
atretic esophageal ends, respectively. In patients with a
gastrostomy tube, by introducing a bougie into the upper
pouch and another into the lower pouch through
gastrostomy, the gap was evaluated by radiological means
(Fig. 1). In patients who underwent thoracotomy for
ligation of TEF, assessment of the gap between the
atretic esophageal segments was performed during the
surgical intervention (Fig. 2). Demographic data included
maternal age, the number of parities and deliveries, the
presence of polyhydramnios and the prenatal diagnosis,
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sex, the gestational age and prematurity, the type of
delivery and the birth weight, age at the time of diagnosis
and treatment, the presence of associated anomalies
including VACTERL-type and non-VACTERL-type
anomalies, the type of EA according to Gross classifica-
tion, and discrepancies between the diameters of atretic
esophageal ends. VACTERL association was defined if
the patient had two or more anomalies of the vertebral,
anorectal, cardiac (excluding patent ductus arteriosus,
patent foramen ovale), renal/genitourinary, and limb
systems.
Statistical analyses
Statistical analyses were performed using IBM SPSS
(ver. 18; IBM Co., Armonk, New York, USA). Data are
presented as mean ± SD, median (interquartile range)
according to their distribution. Qualitative variables were
expressed as percentages. Distribution of numerical data
was assessed by graphical and statistical methods.
Statistical analysis was performed with Student’s t-test
to compare numerical values with normal distribution. To
compare numerical values with an abnormal dispersal
range, interquartile ranges were assessed using the
Mann–Whitney U-test. Fisher’s exact test and w2-tests
were used for the comparison of categorical data.
A P-value of less than 0.05 was considered statistically
significant.
Results
There were 99 patients treated for the diagnosis of EA
spectrum during the study period, and the distribution of
anatomical types of EA is shown in Table 1. Of the
included patients, 81 were in the SGEA group and 18
were in the LGEA group. The characteristics of patients
with SGEA and LGEA are depicted in Table 2. Most of
the parameters studied did not differ between the two
groups. Type-C EA (n = 77/81) was more prevalent in
patients with SGEA and type-A (n = 8/18) was more
frequent in children with LGEA (P < 0.05). The
frequency of prenatal diagnosis (2.5% for SGEA vs.
22.2% for LGEA) was more common in the LGEA group
(P < 0.05). Cesarean section was seen to occur more
commonly than normal vaginal delivery in both groups
(56.8% for SGEA vs. 66.7% for LGEA). Durations of
ventilatory support (14.4 ± 2.5 vs. 36.0 ± 8.4 days;
P < 0.05) and hospital stay (30.0 ± 3.8 vs. 69.7 ± 15.2
days; P < 0.05) were longer in the LGEA group. Patients
with LGEA had a higher mortality rate (35.8 vs. 55.6%;
P < 0.05).
Discussion
The rate of EA may be related to the maternal age, and in
a study where maternal age was analyzed, both young
(< 20 years) and older (> 35 years) mothers were shown
to have an increased risk [9]. In a recent study, compared
with children of mothers younger than 20 years, children
of women giving birth at 35–40 years and above 40 years
showed a two-fold and three-fold increased risk of EA,
respectively [10]. In a most recent cohort from France,
the median age of mothers giving birth to a newborn with
EA at delivery was 30 years [11]. In another study, the
mean ages of mothers of children with LGEA and SGEA
were 30.1 and 28.9 years, respectively [12]. Average ages
of mothers in both groups in the current study did not
show a statistically significant difference, but as a whole,
they were found to be lower compared with those
reported previously [9,10,12]. This finding may be
explained by true population differences including
biologic and environmental factors concerning the ages
of the mothers.
Fig. 1
Measurement of esophageal gap by radiologic examination in patients
with gastrostomy. Note a metal bougie in the upper pouch and another
in the lower pouch.
Fig. 2
Intraoperative assessment of the esophageal gap between the atretic
esophageal segments in a child with esophageal atresia.
Table 1 Distribution of anatomical types of esophageal atresia
Anatomical types of esophageal atresia n
Esophageal atresia with a distal tracheoesophageal fistula 87
Esophageal atresia without tracheoesophageal fistula 8
Tracheoesophageal fistula without esophageal atresia 3
Esophageal web 1
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Parity may be an independent risk factor for birth defects.
Associations between maternal parity, the number of
deliveries, and birth defects have been observed pre-
viously: compared with primiparous mothers, nulliparous
mothers were more likely to have infants with a number
of congenital birth defects including EA [13]. Our series
is dissimilar to this finding in that there were only one
and three nulliparous mothers giving birth to patients
with LGEA and SGEA, respectively. Although there is
no definite explanation for this finding, variability in
population compositions might have played a role.
Although the mean number parities of mothers giving
birth to children with LGEA was found to be higher than
those of mothers with babies having SGEA, the median
number of parities and deliveries in this study did not
show statistical significance between the two groups.
Research on the biologic or environmental factors that
may be associated with the number of maternal parities
and birth defects may be helpful in explaining some or all
of these possible associations.
Polyhydramnios is an important clinical sign in the
diagnosis of EA, but usually it is not apparent until the
third trimester [14]. The rate of polyhydramnios in
mothers who give birth to a newborn with EA ranges from
20 to 30% [14–16]. In a recent study, it was reported that
EA associated with chromosomal or structural anomalies
was associated with greater occurrence of polyhydramnios
with a rate of 53% [17]. In a recent cohort comprising 307
new esophageal cases, polyhydramnios was present in
53.5% of the cases [18]. The 17.2% rate of polyhydram-
nios in the present study was lower than those reported
previously [11,14–16]. This may be explained by the
relatively low number of prenatally diagnosed cases
included in our series than have been included in
previously published series. Although not statistically
significant, another finding in our series was that children
with LGEA were associated with a greater occurrence of
polyhydramnios than patients with SGEA (27.8 vs.
14.8%).
Prenatal diagnosis of EA before the third trimester is
difficult and the prenatal detection rate of EA is low [18].
It was reported that prenatal detection was possible in 9.2
and 24% of cases, respectively [19,20]. In a recent report
comprising 23 registries, it was found that prenatal
detection rates of EA varied by registry from more than
50% to less than 10% of cases, and it was also claimed that
the prenatal detection rate increased from 26 to 36.5%
over the last two decades [21]. In the current study, the
rate of prenatal diagnosis of LGEA was much higher than
that of SGEA (P < 0.05), a finding similar to a recent
report [11]. The ratio of 22.2% in the prenatal diagnosis
regarding LGEA patients in our study is comparable to
the literature, whereas that of patients with SGEA (2.5%)
is lower than that reported [18,21]. We do not have an
explanation for this finding, which demands more
aggressive attempts to conduct prenatal diagnosis. As
regular antenatal check-up programs increase, it is
anticipated that the prenatal detection rates of EA will
increase in the future.
The ratio of male to female was 1.06 in our study. In 15
EUROCAT registries covering 1 546 889 births for EA,
62% of the cases were male [22]. Other studies have
reported either a small or no excess of male pa-
tients [9,23,24]. In a most recent report, the sex ratio
(male/female) was found to be 1.3 [10]. We found a sex
ratio of 1.57 for LGEA in favor of male patients, a result
similar to that found in the literature [25]. In contrast,
our finding of a sex ratio of 0.98 against male patients
among children with SGEA is unlike that of Bianca and
Ettore [25], who reported a ratio of 1.5 in favor of male
patients. Although there is no definite explanation for
this finding in the present study, variability of causes
linked to genetics and the gene–environment interaction
may be involved.
Table 2 Demographic data for patients with short-gap esophageal atresia versus long-gap esophageal atresia
Parameters Short-gap EA Long-gap EA P
Maternal age (years)a 26.15 ± 5.85 25.17 ± 4.94 0.46
Number of parityb (range) 1 (1–4) 2 (1–4) 0.50
Number of deliveriesb (range) 1 (1–4) 1 (1–4) 0.92
Polyhydramnios ratio 12/81 (14.8%) 5/18 (27.8%) 0.18
Prenatal diagnosis ratio 2/81 (2.5%) 4/18 (22.2%) 0.009
Gender (F/M) 41/40 7/11 0.36
Gestational agea 37.23 ± 2.64 36.0 ± 2.97 0.08
Prematurity 15/81 (18.5%) 5/18 (27.8%) 0.37
Type of delivery (NVD/CS) 35/46 6/12 0.44
Birth weight (g)a 2504.44 ± 651.16 2325.0 ± 636.14 0.29
Age at diagnosis (days)b (range) 1 (1–6) 1 (1–6) 0.07
Age at treatment (days)b (range) 3 (1–7) 3 (1–7) 0.30
Days on ventilatory supportb (range) 14.45 ± 17.24 (0–100) 36.0 ± 31.6 (0–100) 0.002
Days of hospital stay (range) 30.03 ± 33.54 (3–270) 69.72 ± 64.28 (3–270) 0.001
Follow-up (months)b (range) 63.46 ± 38.2 (5–81) 48.29 ± 22.48 (5–81) 0.3
Presence of associated anomalies (non/NV/V) 20/8/53 3/1/14 0.59
Type of EA (Gross classification) C (n = 77)/non-Cc (n = 4) C (n = 10)/non-Cd (n = 8) 0.001
Discrepancy in diameters of atretic esophageal endsb (range) 2 (0–4) 2 (0–4) 0.85
Complications 52/81 (64.2%) 13/18 (72.2%) 0.185
Mortality 29/81 (35.8%) 10/18 (55.6%) 0.047
CS, cesarean section; EA, esophageal atresia; F, female; M, male; NV, non-VACTERL; NVD, normal vaginal delivery; V, VACTERL.
aData are presented as mean ± SD.
bData are presented as median (interquartile range).
cClass E + class web.
dClass A.
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The current study did not show differences between the
groups with regard to the gestational age and the age at
diagnosis and treatment. This finding is consistent with
that of the studies by Bagolan et al. [6]. In contrast,
studies by Al-Shanafey and Harvey [12] and Lopes and
Botelho [2] demonstrated that patients with LGEA were
born at an earlier gestational age. In a most recent cohort,
children with LGEA had a lower birth weight than
children with SGEA [11]. Although children with LGEA
had a lower birth weight and a high rate of prematurity
compared with patients with SGEA in this study, we did
not find any statistically significant difference between
the groups, a finding unlike the study by Lopes and
Botelho [2]. Dissimilarities in the present series con-
cerning the birth weight and prematurity may be
attributed to discrepancies pertaining to the demography
of the study population.
Concerning the type of delivery in our study, most of the
patients in both groups were delivered by cesarean
section. This finding is consistent with that of the study
by Chang et al. [15], who reported that 44 out of 72 babies
with EA were born through cesarean section. In contrast,
in a study by Aslanabadi et al. [26], it was found that
patients with LGEA but not SGEA were delivered more
often by a cesarean section. We speculate that materno-
fetal factors might have been involved in the type of
delivery in these patients. Further comprehensive in-
vestigations on the choice of the delivery type in these
patients may give clear knowledge on this issue.
Full or partial VACTERL spectrum defects have been
reported in 10–67% of the neonates with EA [27–32].
Similar to this range, we found VACTERL association in
67% of the children with EA in our study. The prevalence of
non-VACTERL-type anomalies in patients with EA ranges
from 20 to 70%, and our rate of 9% for non-VACTERL-type
anomalies is lower compared with previous stu-
dies [27,33–35]. Our study revealed that the prevalence
of associated anomalies including VACTERL type were
comparable between the groups. This finding is consistent
with that of the study by Lopes and Botelho [2].
Concerning the number of ribs, two of the patients in the
LGEA group had 13 pairs of ribs, whereas none of those
with SGEA had such a skeletal anomaly. Also, both groups in
the current study showed similarities concerning the
prevalence of associated non-VACTERL-type anomalies.
This finding is different from that of study by Aslanabadi
et al. [26], which reports more frequent non-VACTERL-
type anomalies in patients with LGEA. Variations in our
series may be due to genetic and geographic differences
pertaining to our study population.
The other noticeable finding of this study regarding the type
of EA according to the Gross classification was that type-C
was more prevalent in patients with SGEA and type-A was
more frequent in children with LGEA. Although there are
conflicting reports, this finding has been considered as a
description of LGEA by some authors in that there may be
an association between the absence of TEF and LGEA [12].
Apart from the type of EA, both groups of patients did not
show any difference with regard to the discrepancy in the
diameter of atretic esophageal ends.
As may be expected, both the duration of ventilatory
support and the length of hospital stay were found to be
higher in children with LGEA compared with those of
patients with SGEA in the current study (P < 0.05). In a
previous study, the median length of hospital stay for
patients with LGEA was found to be 83 days, a finding
higher than that of ours [36]. In a recent cohort, the
median durations of ventilation and of first hospital stay
were 3 and 22 days, respectively [11]. Nevertheless,
infants with LGEA spend a long time in hospital and
need more time under ventilatory support compared with
those with SGEA. Complications and long-term problems
are frequently seen in patients with EA during treatment.
The incidence of early and late complications during
treatment and the follow-up duration did not differ
between the two groups in the current study. Although of
a limited time period, the follow-up duration in our study
was comparable to that reported previously [14]. Long-
term multidisciplinary follow-up seems to be beneficial in
these patients [37,38].
Nevertheless, there are limitations in this report. The
retrospective design and the limited number of patients
could impact the validity of the data. Moreover, eight
different surgeons managed our patients. This could
bring up individual variations between the surgeons with
different degrees of experience and technical skills.
However, our discrimination of LGEA and SGEA was
objective considering a gap of three VB as a cutoff value.
We believe that using uniform criteria to measure the gap
length in prospective studies involving more patients may
allow us to compare results from different institutions.
With this approach, it may be possible to shed light on
this issue, providing fundamental information.
Conclusion
Most of the demographic parameters studied were similar
between the two groups of patients in this series.
However, the frequency of prenatal diagnosis was more
common in patients with LGEA. Most of the patients in
both groups were delivered by a cesarean section.
Concerning the type of EA according to the Gross
classification, type-C was more prevalent in patients with
SGEA and type-A was more frequent in children with
LGEA. The duration on ventilatory support and the
hospital stay were higher in children with LGEA. Further
prospectively designed population-based registries are
necessary and may be beneficial in revealing the true
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